Singapore biomedical firm to test new rapid diagnostic kit for flu

Credo Biomedical's rapid diagnostics test was developed through a mixture of innovation by its research team and scientific patents that have expired and are therefore now available to all.
Credo Biomedical's rapid diagnostics test was developed through a mixture of innovation by its research team and scientific patents that have expired and are therefore now available to all.PHOTO: CREDO BIOMEDICAL

HONG KONG - A Singapore company believes it has moved a step nearer eliminating deaths due to complications from influenza by developing an on-the-spot test which it claims is more accurate than those currently on the market.

Credo Biomedical's rapid diagnostics test was developed through a mixture of innovation by its research team and scientific patents that have expired and are therefore now available to all.

Please or to continue reading the full article. Learn more about ST PREMIUM.

Enjoy unlimited access to ST's best work

  • Exclusive stories and features on multiple devices
  • In-depth analyses and opinion pieces
  • ePaper and award-winning multimedia content